The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk
Open accessAbstract
The 'unopposed oestrogen hypothesis' for endometrial cancer maintains that risk is increased by exposure to endogenous or exogenous oestrogen that is not opposed simultaneously by a progestagen, and that this increased risk is due to the induced mitotic activity of the endometrial cells. Investigation of the mitotic rate during the menstrual cycle shows that increases in plasma oestrogen concentration above the relatively low levels of the early follicular phase do not produce any further increase in the mitotic rate of endometrial cells. A modification of the unopposed oestrogen hypothesis which includes this upper limit in the response of endometrial cells to oestrogen is consistent with the known dose-effect relationships between endometrial cancer risk and both oestrogen replacement therapy and postmenopausal obesity; it also suggests that the mechanism by which obesity increases risk in premenopausal women involves progesterone deficiency rather than oestrogen excess, and that the protective effect of cigarette smoking may be greater in postmenopausal than in premenopausal women. Detailed analysis of the age-incidence curve for endometrial cancer in the light of this hypothesis suggests that there will be lifelong effects of even short duration use of exogenous hormones. In particular, 5 years of combination-type oral contraceptive use is likely to reduce a woman's lifetime risk of endometrial cancer by some 60%; whereas 5 years of unopposed oestrogen replacement therapy is likely to increase her subsequent lifetime risk by at least 90%; and even 5 years of 'adequately' opposed therapy is likely to increase subsequent lifetime risk by at least 50%.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ANDERSON, D. C. (1974) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1974.tb03298.x · Cited by 1,127
‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer
Pike, M. C., Krailo, M. D., Henderson, B. E., Casagrande, J. T., & Hoel, D. G. (1983) · Nature · doi:10.1038/303767a0 · Cited by 697
Self-citationMichnovicz, J. J., Hershcopf, R. J., Naganuma, H., Bradlow, H. L., & Fishman, J. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611203152101 · Cited by 658
Endogenous hormones as a major factor in human cancer.
Henderson, B. E., Ross, R. K., Pike, M. C., & Casagrande, J. T. (1982) · PubMed · Cited by 602
Self-citationEstrogens and Endometrial Cancer in a Retirement Community
Mack, T. M., Pike, M. C., Henderson, B. E., Pfeffer, R. I., Gerkins, V. R., Arthur, M., & Brown, S. E. (1976) · New England Journal of Medicine · doi:10.1056/nejm197606032942304 · Cited by 557
Self-citationEpidemiology of Endometrial Cancer 2
Elwood, J. M., Cole, P., Rothman, K. J., & Kaplan, S. D. (1977) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/59.4.1055 · Cited by 430
Cigarette Smoking and Urinary Estrogens
MacMahon, B., Trichopoulos, D., Cole, P., & Brown, J. (1982) · New England Journal of Medicine · doi:10.1056/nejm198210213071707 · Cited by 404
Whitehead, M. I., Townsend, P. T., Pryse-Davies, J., Ryder, T. A., & King, R. J. B. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112313052701 · Cited by 396
Endometrial Cancer and Estrogen Use: Report of a Large Case-Control Study
Antunes, C. M. F., Stolley, P. D., Rosenshein, N. B., Davies, J. L., Tonascia, J. A., Brown, C., Burnett, L., Rutledge, A., Pokempner, M., & Garcia, R. (1979) · New England Journal of Medicine · doi:10.1056/nejm197901043000103 · Cited by 388
Jensen, J., Christiansen, C., & Rødbro, P. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510173131602 · Cited by 382
Cited by
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Morice, P., Leary, A., Creutzberg, C., Abu-Rustum, N., & Darai, E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00130-0 · Cited by 1,514
Reeves, G. K., Pirie, K., Beral, V., Green, J., Spencer, E., & Bull, D. (2007) · BMJ · doi:10.1136/bmj.39367.495995.ae · Cited by 1,507
Ovarian cancer and hormone replacement therapy in the Million Women Study
Beral, V. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60534-0 · Cited by 937
Overweight, obesity, and cancer risk
Bianchini, F., Kaaks, R., & Vainio, H. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00849-5 · Cited by 929
Henderson, B. E., & Feigelson, H. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.427 · Cited by 821
Type I and II Endometrial Cancers: Have They Different Risk Factors?
Setiawan, V. W., Yang, H. P., Pike, M. C., McCann, S. E., Yu, H., Xiang, Y.-B., Wolk, A., Wentzensen, N., Weiss, N. S., Webb, P. M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.2596 · Cited by 827
Self-citationCalle, E. E., & Thun, M. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207751 · Cited by 769
The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer
Key, T. J. A., & Pike, M. C. (1988) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(88)90173-3 · Cited by 651
Self-citationDiet, nutrition and the prevention of cancer
Key, T. J., Schatzkin, A., Willett, W. C., Allen, N. E., Spencer, E. A., & Travis, R. C. (2004) · Public Health Nutrition · doi:10.1079/phn2003588 · Cited by 648
Self-citationEnergy balance and cancer: the role of insulin and insulin-like growth factor-I
Kaaks, R., & Lukanova, A. (2001) · Proceedings of the Nutrition Society · doi:10.1079/pns200070 · Cited by 615
Endometrial cancer and hormone-replacement therapy in the Million Women Study
(2005) · The Lancet · doi:10.1016/s0140-6736(05)66455-0 · Cited by 613
Barry, J. A., Azizia, M. M., & Hardiman, P. J. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu012 · Cited by 597
Diabetes mellitus and risk of endometrial cancer: a meta-analysis
Friberg, E., Orsini, N., Mantzoros, C. S., & Wolk, A. (2007) · Diabetologia · doi:10.1007/s00125-007-0681-5 · Cited by 562
Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer
Kim, J. J., Kurita, T., & Bulun, S. E. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1043 · Cited by 520
The effect of diet on risk of cancer
Key, T. J., Allen, N. E., Spencer, E. A., & Travis, R. C. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09958-0 · Cited by 493
Self-citationIs Estradiol a Genotoxic Mutagenic Carcinogen?1
Liehr, J. G. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0386 · Cited by 484
Obesity and cancer risk: a danish record-linkage study
Møller, H., Mellemgaard, A., Lindvig, K., & Olsen, J. H. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90254-2 · Cited by 448
Epidemiology of male breast cancer
Konduri, S., Singh, M., Bobustuc, G., Rovin, R., & Kassam, A. (2020) · The Breast · doi:10.1016/j.breast.2020.08.010 · Cited by 411
Epidemiology of Endocrine-Related Risk Factors for Breast Cancer
Bernstein, L. (2002) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1015714305420 · Cited by 401
The epidemiology of endometrial cancer
Parazzini, F., La Vecchia, C., Bocciolone, L., & Franceschi, S. (1991) · Gynecologic Oncology · doi:10.1016/0090-8258(91)90246-2 · Cited by 400
Nutrition, hormones, and breast cancer: Is insulin the missing link?
Kaaks, R. (1996) · Cancer Causes and Control · doi:10.1007/bf00051703 · Cited by 360
Toward the Primary Prevention of Cancer
Henderson, B. E., Ross, R. K., & Pike, M. C. (1991) · Science · doi:10.1126/science.1957166 · Cited by 355
Self-citationEndometrial cancer and obesity: Epidemiology, biomarkers, prevention and survivorship
Fader, A. N., Arriba, L. N., Frasure, H. E., & von Gruenigen, V. E. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.03.039 · Cited by 354
Obesity and weight management in the elderly
Han, T. S., Tajar, A., & Lean, M. E. J. (2011) · British Medical Bulletin · doi:10.1093/bmb/ldr002 · Cited by 327
Association of Soy and Fiber Consumption with the Risk of Endometrial Cancer
Goodman, M. T., Wilkens, L. R., Hankin, J. H., Lyu, L.-C., Wu, A. H., & Kolonel, L. N. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009270 · Cited by 329
Estrogen-Progestin Replacement Therapy and Endometrial Cancer
Pike, M. C., Peters, R. K., Cozen, W., Probst-Hensch, N. M., Wan, P. C., Mack, T. M., & Felix, J. C. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.15.1110 · Cited by 315
Self-citationCase--Control Study of Endogenous Steroid Hormones and Endometrial Cancer
Potischman, N., Hoover, R. N., Brinton, L. A., Siiteri, P., Dorgan, J. F., Swanson, C. A., Berman, M. L., Mortel, R., Twiggs, L. B., Barrett, R. J., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1127 · Cited by 297
Dossus, L., Allen, N., Kaaks, R., Bakken, K., Lund, E., Tjonneland, A., Olsen, A., Overvad, K., Clavel‐Chapelon, F., Fournier, A., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25050 · Cited by 296
Self-citationOvarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles
McConechy, M. K., Ding, J., Senz, J., Yang, W., Melnyk, N., Tone, A. A., Prentice, L. M., Wiegand, K. C., McAlpine, J. N., Shah, S. P., et al. (2014) · Modern Pathology · doi:10.1038/modpathol.2013.107 · Cited by 288
AKHMEDKHANOV, A., ZELENIUCH‐JACQUOTTE, A., & TONIOLO, P. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03811.x · Cited by 269
Circulating hormones and estrous stage predict cellular and stromal remodeling in murine uterus
Wood, G. A., Fata, J. E., Watson, K. L. M., & Khokha, R. (2007) · Reproduction · doi:10.1530/rep-06-0302 · Cited by 268
Allen, N. E., Key, T. J., Dossus, L., Rinaldi, S., Cust, A., Lukanova, A., Peeters, P. H., Onland-Moret, N. C., Lahmann, P. H., Berrino, F., et al. (2008) · Endocrine Related Cancer · doi:10.1677/erc-07-0064 · Cited by 268
Self-citationRisks of breast and endometrial cancer after estrogen and estrogen–progestin replacement
Persson, I., Weiderpass, E., Bergkvist, L., Bergström, R., & Schairer, C. (1999) · Cancer Causes & Control · doi:10.1023/a:1008909128110 · Cited by 258
Inflammation and Endometrial Cancer: A Hypothesis
Modugno, F., Ness, R. B., Chen, C., & Weiss, N. S. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0493 · Cited by 254
USA endometrial cancer projections to 2030: should we be concerned?
Sheikh, M. A., Althouse, A. D., Freese, K. E., Soisson, S., Edwards, R. P., Welburn, S., Sukumvanich, P., Comerci, J., Kelley, J., LaPorte, R. E., et al. (2014) · Future Oncology · doi:10.2217/fon.14.192 · Cited by 236
O’Mara, T. A., Spurdle, A. B., Glubb, D. M., & Endometrial Cancer Association Consortium (2019) · Cancers · doi:10.3390/cancers11101440 · Cited by 36
Badhwar, R., Kaur, G., Popli, H., Yadav, D., & Buttar, H. S. (2020) · Pathophysiology of Obesity-Induced Health Complications · doi:10.1007/978-3-030-35358-2_19 · Cited by 3
Metadata
- Authors
- Key, T., & Pike, M.
- Venue
- British Journal of Cancer
- Published
- 1988-02
- Volume
- 57
- Issue
- 2
- Pages
- 205-212
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2086880154
- Cited by
- 547
- References
- 43
- FWCI
- 4.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.